National Centre for Neuroimmunology and Emerging Diseases

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 18:12, June 1, 2018 by Kmdenmark (talk | contribs) (→‎See also: added name)

The National Centre for Neuroimmunology and Emerging Disease (NCNED) is an Australian research group led by Sonya Marshall-Gradisnik and Donald Staines.[1]

The NCNED is a part of Griffith University Health, in south-east Queensland.

Potential biomarker[edit | edit source]

In February 2016 the research team led by Donald Staines and Sonya Marshall-Gradisnik announced it had created a diagnostic test for the disease using CD8 T cells.[2][3][4][5][6][7][8] The researchers have submitted patent claims in relation to their discovery.[9][10][11]

Professor Sonya Marshall-Gradisnik clarified that 'In response to a number of inquiries of this nature we are pleased to advise that we have both published papers, papers in press, and additional data not for publication, which constitutes commercial-in-confidence'.[12][13]

Notable studies[edit | edit source]

Funding[edit | edit source]

The NCNED is supported by the Queensland Government and philanthropic donors.[14]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ https://www.griffith.edu.au/health/national-centre-neuroimmunology-emerging-diseases/our-team
  2. ↑ Australian scientists make breakthrough in Chronic Fatigue Syndrome testing, ABC News (Australia), 29 February 2016
  3. ↑ Griffith Uni claims breakthrough on diagnostic test, #MEAction, February 29, 2016
  4. ↑ Screening test for Chronic Fatigue Syndrome on its way, Griffith University, 1 March 2016
  5. ↑ A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis’., Journal of Immunology Research, Volume 2016 (2016), Article ID 9064529, 8 pages
  6. ↑ New Screening Test for ME/CFS Announced by Griffith University, CFS Treatment Guide, 5 Mar 2016
  7. ↑ Chronic fatigue syndrome: new diagnostic tool to speed up treatment and reduce stigma
  8. ↑ A screening test for chronic fatigue syndrome is ready for the public
  9. ↑ Patent AusPat 2015904991, IP Australia, 2 December 2015
  10. ↑ Patent AusPat 2015901567, IP Australia, 1 June 2015
  11. ↑ Biological markers - WO 2016023077 A1
  12. ↑ Statement from NCNED, Griffith University, 1 March 2016
  13. ↑ Letter from Sonya Marshall-Gradisnik, Twitter, 1 March 2016
  14. ↑ NCNED Partnerships

T cell A type of white blood cell which is mostly produced or matured in the thymus gland (hence T-cell) and is involved in the adaptive immune response on a cellular level. Also known as a T lymphocyte. (Learn more: www.youtube.com)

International Consensus Criteria (ICC) - A set of diagnostic criteria, based on the Canadian Consensus Criteria, that argued for the abandonment of the term "chronic fatigue syndrome" and encouraged the sole use of the term "myalgic encephalomyelitis".

Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.

World Health Organization (WHO) - "A specialized agency of the United Nations that is concerned with public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organization, was an agency of the League of Nations." The International Statistical Classification of Diseases and Related Health Problems (ICD) is maintained by WHO.

Retrieved from "https://me-pedia.org/w/index.php?title=National_Centre_for_Neuroimmunology_and_Emerging_Diseases&oldid=31693"